Autoimmunity	NN
to	TO
Vimentin	NNP
Is	VBZ
Associated	VBN
with	IN
Outcomes	NNS
of	IN
Patients	NNS
with	IN
Idiopathic	JJ
Pulmonary	JJ
Fibrosis	NN
.	.

Autoimmunity	NN
has	VBZ
been	VBN
implicated	VBN
in	IN
the	DT
pathogenesis	NN
of	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
;	:
however	RB
,	,
the	DT
repertoire	NN
of	IN
autoantigens	NNS
involved	VBN
in	IN
this	DT
disease	NN
and	CC
the	DT
clinical	JJ
relevance	NN
of	IN
these	DT
autoimmune	JJ
responses	NNS
are	VBP
still	RB
being	VBG
explored	VBN
.	.

Our	PRP$
initial	JJ
discovery	NN
assays	NNS
demonstrated	VBD
that	IN
circulating	VBG
and	CC
intrapulmonary	JJ
vimentin	NN
levels	NNS
are	VBP
increased	VBN
in	IN
IPF	NN
patients	NNS
.	.

Subsequent	JJ
studies	NNS
showed	VBD
native	JJ
vimentin	NN
induced	VBD
HLA-DR-dependent	JJ
in	FW
vitro	FW
proliferation	NN
of	IN
CD4	NN
T	NN
cells	NNS
from	IN
IPF	NN
patients	NNS
and	CC
enhanced	VBD
the	DT
production	NN
of	IN
IL-4	NN
,	,
IL-17	NN
,	,
and	CC
TGF-b1	NN
by	IN
these	DT
lymphocytes	NNS
in	IN
contrast	NN
to	TO
normal	JJ
control	NN
specimens	NNS
.	.

Vimentin	NN
supplementation	NN
of	IN
IPF	NN
PBMC	NN
cultures	NNS
also	RB
resulted	VBD
in	IN
HLA-DR-dependent	JJ
production	NN
of	IN
IgG	NN
with	IN
anti-vimentin	JJ
specificities	NNS
.	.

Circulating	VBG
anti-vimentin	JJ
IgG	NN
autoantibody	NN
levels	NNS
were	VBD
much	RB
greater	JJR
in	IN
IPF	NN
subjects	NNS
from	IN
the	DT
University	NNP
of	IN
Alabama	NNP
at	IN
Birmingham	NNP
(	(
n	NN
=	JJ
102	CD
)	)
and	CC
the	DT
University	NNP
of	IN
Pittsburgh	NNP
(	(
U.	NNP
Pitt.	NNP
,	,
n	NN
=	JJ
70	CD
)	)
than	IN
in	IN
normal	JJ
controls	NNS
.	.

Anti-vimentin	JJ
autoantibody	NN
levels	NNS
in	IN
IPF	NN
patients	NNS
were	VBD
HLA	NN
biased	VBN
and	CC
inversely	RB
correlated	VBD
with	IN
physiological	JJ
measurements	NNS
of	IN
lung	NN
function	NN
(	(
i.e.	FW
,	,
forced	VBD
expiratory	JJ
volumes	NNS
and	CC
diffusing	VBG
capacities	NNS
)	)
.	.

Despite	IN
considerable	JJ
intergroup	NN
differences	NNS
in	IN
transplant-free	JJ
survival	NN
between	IN
these	DT
two	CD
independent	JJ
IPF	NN
cohorts	NNS
,	,
serious	JJ
adverse	JJ
outcomes	NNS
were	VBD
most	RBS
frequent	JJ
among	IN
the	DT
patients	NNS
within	IN
each	DT
population	NN
that	WDT
had	VBD
the	DT
highest	JJS
anti-vimentin	JJ
autoantibody	NN
levels	NNS
(	(
University	NNP
of	IN
Alabama	NNP
at	IN
Birmingham	NNP
:	:
hazard	NN
ratio	NN
2.5	CD
,	,
95	CD
%	NN
confidence	NN
interval	NN
1.2-5.3	CD
,	,
p	NN
=	JJ
0.012	CD
;	:
University	NNP
of	IN
Pittsburgh	NNP
:	:
hazard	NN
ratio	NN
2.7	CD
,	,
95	CD
%	NN
confidence	NN
interval	NN
1.3-5.5	CD
,	,
p	NN
=	JJ
0.006	CD
)	)
.	.

These	DT
data	NNS
show	VBP
that	IN
anti-vimentin	JJ
autoreactivity	NN
is	VBZ
prevalent	JJ
in	IN
IPF	NN
patients	NNS
and	CC
is	VBZ
strongly	RB
associated	VBN
with	IN
disease	NN
manifestations	NNS
.	.

These	DT
findings	NNS
have	VBP
implications	NNS
with	IN
regard	NN
to	TO
the	DT
pathogenesis	NN
of	IN
this	DT
enigmatic	JJ
disease	NN
and	CC
raise	VB
the	DT
possibility	NN
that	IN
therapies	NNS
specifically	RB
directed	VBN
at	IN
these	DT
autoimmune	JJ
processes	NNS
could	MD
have	VB
therapeutic	JJ
efficacy	NN
.	.

